Difference between revisions of "Hans Groth"
(tidy,unstub) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
|wikipedia= | |wikipedia= | ||
|amazon= | |amazon= | ||
| − | |description= | + | |description=Senior Director for Healthcare Policy & Market Access, Oncology Business Unit, at [[Pfizer |Pfizer Europe]]. Attended [[2011 Bilderberg]]. |
|linkedin=https://www.linkedin.com/in/hans-groth-ab30006 | |linkedin=https://www.linkedin.com/in/hans-groth-ab30006 | ||
| − | |image=Hans Groth. | + | |image=Hans Groth.png |
| − | |nationality=Swiss | + | |nationality=Swiss,German |
|birth_date= | |birth_date= | ||
|birth_place= | |birth_place= | ||
| Line 11: | Line 11: | ||
|death_place= | |death_place= | ||
|constitutes=businessman | |constitutes=businessman | ||
| + | |employment={{job | ||
| + | |title=Senior Director for Healthcare Policy & Market Access | ||
| + | |start=1988 | ||
| + | |end=2012 | ||
| + | |employer=Pfizer | ||
| + | |description=Attended [[2011 Bilderberg]]. | ||
}} | }} | ||
| − | '''Hans Groth''' was described as "Senior Director, Healthcare Policy & Market Access, Oncology Business Unit, Pfizer Europe" on the [[2011 Bilderberg]] guest list. | + | }} |
| + | '''Hans Groth''' was described as "Senior Director, Healthcare Policy & Market Access, Oncology Business Unit, Pfizer Europe" on the [[2011 Bilderberg]] guest list. From 2009, he is also Chairman of the Board at the [[Big Pharma]]-sponsored<ref>https://www.wdaforum.org/kooperationen/partner-kooperationen-spenden/partner-foerderkreis</ref> [[World Demographic & Ageing Forum]]. | ||
==Career== | ==Career== | ||
| − | + | Till [[2012]] Groth has been working with [[Pfizer Inc.]] for twenty-four years. He has comprehensive experience in over 30 [[healthcare markets]] including [[Western Europe]], [[Eastern Europe]], the [[USA]] and [[Canada]]. His responsibilities have included medical affairs, clinical research, [[regulatory]], marketing & sales as well as international public affairs including negotiating pricing & access conditions with government authorities, [[NGOs]] as well as [[healthcare payers]].<ref name=demographic>https://demographic-challenge.com/files/downloads/45153ab97b0f2e657854069035807b30/cv-dr-hans-groth-2013-englisch.pdf</ref> | |
| + | |||
| + | In 2003, he was appointed “Pfizer Global Health Fellow” by [[UNAIDS]] to conduct case studies in [[Central Asia]] and [[Siberia]] in order to quantify the threat potential of [[AIDS|HIV/AIDS/TB]] in that region.<ref name=demographic/> | ||
| + | |||
| + | He is President of [[Academia Engelberg Foundation]], "a platform for dialogue between science and society". Since [[2009]], he has been permanent guest lecturer at the [[University of St Gallen]] (HSG), Switzerland. His focus of research built upon "theories of economic development and productivity, and employing the value of health, education and progress in societal governance as sustainable tools to unlock new ways to tackle the imminent challenges of demographic change."<ref>https://www.weforum.org/people/hans-groth</ref> | ||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
| − | |||
Latest revision as of 05:15, 19 July 2022
 Hans Groth    (businessman) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ||||||||||||||
| Nationality | Swiss, German | |||||||||||||
Senior Director for Healthcare Policy & Market Access, Oncology Business Unit, at Pfizer Europe. Attended 2011 Bilderberg.
| ||||||||||||||
Hans Groth was described as "Senior Director, Healthcare Policy & Market Access, Oncology Business Unit, Pfizer Europe" on the 2011 Bilderberg guest list. From 2009, he is also Chairman of the Board at the Big Pharma-sponsored[1] World Demographic & Ageing Forum.
Career
Till 2012 Groth has been working with Pfizer Inc. for twenty-four years. He has comprehensive experience in over 30 healthcare markets including Western Europe, Eastern Europe, the USA and Canada. His responsibilities have included medical affairs, clinical research, regulatory, marketing & sales as well as international public affairs including negotiating pricing & access conditions with government authorities, NGOs as well as healthcare payers.[2]
In 2003, he was appointed “Pfizer Global Health Fellow” by UNAIDS to conduct case studies in Central Asia and Siberia in order to quantify the threat potential of HIV/AIDS/TB in that region.[2]
He is President of Academia Engelberg Foundation, "a platform for dialogue between science and society". Since 2009, he has been permanent guest lecturer at the University of St Gallen (HSG), Switzerland. His focus of research built upon "theories of economic development and productivity, and employing the value of health, education and progress in societal governance as sustainable tools to unlock new ways to tackle the imminent challenges of demographic change."[3]
Event Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| Bilderberg/2011 | 9 June 2011 | 12 June 2011 | Switzerland Hotel Suvretta St. Moritz | 59th meeting, in Switzerland, 129 guests |
